#U.S. Listing #Devonian Health Group #stock consolidation

Devonian Health Group Moves Forward with Share Consolidation

Introduction
In a significant move aimed at amplifying its market presence and appeal to prospective investors, Devonian Health Group Inc. has announced the implementation of a share consolidation strategy. This decision, which gained overwhelming approval from shareholders, is geared towards preparing the company for a potential listing on a U.S. stock exchange.

Share Consolidation Details

On January 20, 2026, Devonian revealed plans to consolidate its outstanding common shares at a ratio of one new share for every sixty existing shares. This consolidation, which follows a nearly unanimous shareholder vote of 99.79% during a recent meeting, is expected to enhance the trading price of the shares. This increase is crucial in broadening the investor pool and aligning with the U.S. stock exchanges' minimum trading price requirements, thereby facilitating a smooth transition to the U.S. market.

Timing and Expectations

The share consolidation is set to take effect at the market's opening on or around January 22, 2026. After implementation, Devonian anticipates having approximately 2,765,725 common shares outstanding, subject to adjustments for fractional shares. The firm currently holds 165,943,512 common shares, whose trading symbol will remain